.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Queensland Health
Citi
Farmers Insurance
UBS
Healthtrust
Deloitte
QuintilesIMS
Cipla
Chubb

Generated: December 14, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 006035

« Back to Dashboard

NDA 006035 describes METHERGINE, which is a drug marketed by Edison Theraps Llc and is included in one NDA. It is available from three suppliers. Additional details are available on the METHERGINE profile page.

The generic ingredient in METHERGINE is methylergonovine maleate. There is one drug master file entry for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the methylergonovine maleate profile page.

Summary for 006035

Tradename:1
Applicant:1
Ingredient:1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 006035

Ingredient-typeErgolines

Medical Subject Heading (MeSH) Categories for 006035

Suppliers and Packaging for NDA: 006035

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
METHERGINE methylergonovine maleate INJECTABLE;INJECTION 006035 NDA Apotheca, Inc. 12634-179 12634-179-98 8 TABLET, COATED in 1 BOTTLE, PLASTIC (12634-179-98)
METHERGINE methylergonovine maleate INJECTABLE;INJECTION 006035 NDA Apotheca, Inc. 12634-179 12634-179-80 20 TABLET, COATED in 1 BOTTLE, PLASTIC (12634-179-80)

Summary for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength0.2MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Summary for product number 004

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.2MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
US Army
Citi
Medtronic
Queensland Health
Farmers Insurance
Johnson and Johnson
Argus Health
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot